Healthpeak Properties, Inc. (NYSE:DOC) Shares Sold by Hantz Financial Services Inc.

Hantz Financial Services Inc. trimmed its position in Healthpeak Properties, Inc. (NYSE:DOC) by 4.4% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 99,751 shares of the real estate investment trust’s stock after selling 4,553 shares during the period. Hantz Financial Services Inc.’s holdings in Healthpeak Properties were worth $2,022,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. HM Payson & Co. acquired a new stake in shares of Healthpeak Properties in the third quarter worth approximately $25,000. S.A. Mason LLC purchased a new position in Healthpeak Properties in the 3rd quarter valued at $26,000. Rise Advisors LLC acquired a new stake in Healthpeak Properties during the 3rd quarter worth $29,000. Fortitude Family Office LLC purchased a new stake in shares of Healthpeak Properties during the third quarter worth $32,000. Finally, Barrett & Company Inc. acquired a new stake in shares of Healthpeak Properties in the third quarter valued at about $33,000. 93.57% of the stock is currently owned by hedge funds and other institutional investors.

Healthpeak Properties Stock Performance

NYSE:DOC opened at $20.53 on Friday. The stock has a market capitalization of $14.36 billion, a P/E ratio of 43.67, a PEG ratio of 2.21 and a beta of 1.14. The company has a debt-to-equity ratio of 0.93, a quick ratio of 1.31 and a current ratio of 1.31. Healthpeak Properties, Inc. has a fifty-two week low of $16.01 and a fifty-two week high of $23.26. The company has a 50 day moving average price of $20.79 and a 200 day moving average price of $21.55.

Wall Street Analyst Weigh In

DOC has been the topic of a number of recent research reports. Royal Bank of Canada upped their price objective on shares of Healthpeak Properties from $25.00 to $26.00 and gave the company an “outperform” rating in a research note on Monday, November 4th. StockNews.com lowered Healthpeak Properties from a “hold” rating to a “sell” rating in a research report on Wednesday, October 30th. Morgan Stanley upgraded Healthpeak Properties from an “equal weight” rating to an “overweight” rating and set a $25.00 price objective on the stock in a research report on Wednesday, January 15th. Robert W. Baird upped their target price on Healthpeak Properties from $24.00 to $25.00 and gave the company an “outperform” rating in a report on Wednesday, October 30th. Finally, Wells Fargo & Company reduced their price target on Healthpeak Properties from $23.00 to $22.00 and set an “equal weight” rating on the stock in a report on Tuesday, December 10th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, Healthpeak Properties presently has a consensus rating of “Moderate Buy” and an average target price of $24.15.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.